LOS ANGELES, Dec. 8, 2022 (GLOBE NEWSWIRE) — The law office of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders in the following public companies. Investors have until the deadlines listed below to file a lead plaintiff filing.

Investors who experience losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email at fcruz@frankcruzlaw.com.

Eiger BioPharmaceuticals, Inc. OWN
Class Period: March 10, 2021 – October 4, 2022
Deadline for lead plaintiff: January 9, 2023

The Complaint filed in this Class Action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and failed to disclose material adverse facts about the Company’s business, operations and prospects. In particular, the defendants failed to disclose to investors that: (1) the defendants overvalued Eiger’s clinical and regulatory drug development expertise; (2) Defendants failed to properly assess and/or ignore issues with the TOGETHER study design and its ability to support the peginterferon-lambda EUA; (3) there were issues with the conduct of the TOGETHER study and/or the TOGETHER study was not properly designed for peginterferon lambda EUA in the current context of the pandemic; (4) as a result, it was unlikely that the FDA would approve the filing of a peginterferon lambda EUA; (5) as a result of all this, the regulatory and commercial prospects of peginterferon lambda for the treatment of COVID-19 have been overstated; and (6) as a result, the defendants’ positive statements about the Company’s business, operations and prospects were materially misleading and/or lacking a reasonable basis at all relevant times.

If you are an Eiger shareholder who has suffered a loss, click here take part.

TuSimple Holdings Inc. TSP
Class Period: April 15, 2021 – October 31, 2022
Deadline for lead plaintiff: January 9, …